Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.78 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.72 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4127147 | 0.95 | DPP4 (0.84) | DPP4DPP9DPP8 | |
| Hydrochloric Acid SCHEMBL4113979 | 0.94 | DPP4 (0.87) | DPP4DPP9DPP8 | |
| Hydrochloric Acid SCHEMBL5449842 | 0.87 | DPP4 (1.00) | DPP4DPP9DPP8 | |
| Hydrochloric Acid SCHEMBL5445802 | 0.84 | DPP4 (0.79) | DPP4DPP9DPP8 | |
| SCHEMBL4112626 | 0.84 | DPP4 (1.00) | DPP4DPP9DPP8 | |
| Water SCHEMBL29516207 | 0.83 | DPP4 (1.00) | DPP4DPP9DPP8 | |
| Hydrochloric Acid SCHEMBL4112752 | 0.83 | DPP4 (0.98) | DPP4DPP9DPP8 | |
| SCHEMBL5239332 | 0.83 | DPP4 (0.58) | DPP4DPP9DPP8 | |
| SCHEMBL5447918 | 0.82 | DPP4 (0.62) | DPP4DPP9DPP8 | |
| SCHEMBL5451985 | 0.81 | DPP4 (0.84) | DPP4DPP9DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090088419-A1 | PYRIDYL ACETIC ACID COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-02 | — | — | US | claimed |
| EP-1851202-A1 | PYRIDYL ACETIC ACID COMPOUNDS | Takeda Pharmaceutical Company Limited (JP) | 2007-11-07 | — | — | EP | claimed |
| WO-2006090915-A1 | PYRIDYL ACETIC ACID COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-08-31 | — | — | WO | claimed |
| US-20090088419-A1 | PYRIDYL ACETIC ACID COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-04-02 | — | — | US | disclosed |
| EP-1851202-A1 | PYRIDYL ACETIC ACID COMPOUNDS | Takeda Pharmaceutical Company Limited (JP) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006090915-A1 | PYRIDYL ACETIC ACID COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090088419-A1 | PYRIDYL ACETIC ACID COMPOUNDS | DPP4, GPR119, DPP3 | DPP4 1/4885DPP9 11/4885DPP8 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.